These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30649302)

  • 1. Genome-wide association study of anti-Müllerian hormone levels in pre-menopausal women of late reproductive age and relationship with genetic determinants of reproductive lifespan.
    Ruth KS; Soares ALG; Borges MC; Eliassen AH; Hankinson SE; Jones ME; Kraft P; Nichols HB; Sandler DP; Schoemaker MJ; Taylor JA; Zeleniuch-Jacquotte A; Lawlor DA; Swerdlow AJ; Murray A
    Hum Mol Genet; 2019 Apr; 28(8):1392-1401. PubMed ID: 30649302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
    Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
    Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal menopause as a predictor of anti-Mullerian hormone level and antral follicle count in daughters during reproductive age.
    Bentzen JG; Forman JL; Larsen EC; Pinborg A; Johannsen TH; Schmidt L; Friis-Hansen L; Nyboe Andersen A
    Hum Reprod; 2013 Jan; 28(1):247-55. PubMed ID: 23136135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.
    Broer SL; Broekmans FJ; Laven JS; Fauser BC
    Hum Reprod Update; 2014; 20(5):688-701. PubMed ID: 24821925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The physiology and clinical utility of anti-Mullerian hormone in women.
    Dewailly D; Andersen CY; Balen A; Broekmans F; Dilaver N; Fanchin R; Griesinger G; Kelsey TW; La Marca A; Lambalk C; Mason H; Nelson SM; Visser JA; Wallace WH; Anderson RA
    Hum Reprod Update; 2014; 20(3):370-85. PubMed ID: 24430863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation may modify ovarian reserve in female childhood cancer survivors.
    van Dorp W; van den Heuvel-Eibrink MM; Stolk L; Pieters R; Uitterlinden AG; Visser JA; Laven JS
    Hum Reprod; 2013 Apr; 28(4):1069-76. PubMed ID: 23360674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
    Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
    Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does anti-Müllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study.
    Depmann M; Eijkemans MJ; Broer SL; Scheffer GJ; van Rooij IA; Laven JS; Broekmans FJ
    Hum Reprod; 2016 Jul; 31(7):1579-87. PubMed ID: 27179263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women.
    Freeman EW; Sammel MD; Lin H; Gracia CR
    J Clin Endocrinol Metab; 2012 May; 97(5):1673-80. PubMed ID: 22378815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age at menarche and parity are independently associated with Anti-Müllerian hormone, a marker of ovarian reserve, in Filipino young adult women.
    Bragg JM; Kuzawa CW; Agustin SS; Banerjee MN; McDade TW
    Am J Hum Biol; 2012; 24(6):739-45. PubMed ID: 22915230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated ovarian reserve depletion in female anti-Müllerian hormone knockout mice has no effect on lifetime fertility†.
    Guo R; Pankhurst MW
    Biol Reprod; 2020 Apr; 102(4):915-922. PubMed ID: 31837140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between an AMH promoter polymorphism and serum AMH levels in PCOS patients.
    Moolhuijsen LME; Louwers YV; McLuskey A; Broer L; Uitterlinden AG; Verdiesen RMG; Sisk RK; Dunaif A; Laven JSE; Visser JA
    Hum Reprod; 2022 Jun; 37(7):1544-1556. PubMed ID: 35451015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interindividual variation in ovarian reserve after gonadotoxic treatment in female childhood cancer survivors - a genome-wide association study: results from PanCareLIFE.
    van der Perk MEM; Broer L; Yasui Y; Laven JSE; Robison LL; Tissing WJE; Versluys B; Bresters D; Kaspers GJL; Lambalk CB; Overbeek A; Loonen JJ; Beerendonk CCM; Byrne J; Berger C; Clemens E; van Dulmen-den Broeder E; Dirksen U; van der Pal HJ; de Vries ACH; Winther JF; Ranft A; Fosså SD; Grabow D; Muraca M; Kaiser M; Kepák T; Kruseova J; Modan-Moses D; Spix C; Zolk O; Kaatsch P; Kremer LCM; Brooke RJ; Wang F; Baedke JL; Uitterlinden AG; Bos AME; van Leeuwen FE; Ness KK; Hudson MM; van der Kooi ALF; van den Heuvel-Eibrink MM;
    Fertil Steril; 2024 Sep; 122(3):514-524. PubMed ID: 38729340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study of anti-Mullerian hormone and anti-Mullerian hormone type II receptor polymorphisms with idiopathic primary ovarian insufficiency.
    Yoon SH; Choi YM; Hong MA; Kim JJ; Lee GH; Hwang KR; Moon SY
    Hum Reprod; 2013 Dec; 28(12):3301-5. PubMed ID: 24146295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum anti-Müllerian hormone concentration and follicle density throughout reproductive life and in different diseases-implications in fertility preservation.
    Liebenthron J; Reinsberg J; van der Ven K; Saenger N; Kruessel JS; von Wolff M
    Hum Reprod; 2019 Dec; 34(12):2513-2522. PubMed ID: 31782794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A validated model of serum anti-müllerian hormone from conception to menopause.
    Kelsey TW; Wright P; Nelson SM; Anderson RA; Wallace WH
    PLoS One; 2011; 6(7):e22024. PubMed ID: 21789206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Müllerian hormone as a predictor of reproductive potential.
    Hawkins Bressler L; Steiner A
    Curr Opin Endocrinol Diabetes Obes; 2018 Dec; 25(6):385-390. PubMed ID: 30299431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a place for AMH testing in Canada?
    Green JA; Graves G
    J Obstet Gynaecol Can; 2011 Jun; 33(6):628-632. PubMed ID: 21846454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.